Poseida Therapeutics, Inc. Accounts Payable
Poseida Therapeutics, Inc. had Accounts Payable of $5.20 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-11-07
- 2024-09-30: Accounts Payable, Current $5.20M.
- 2024-06-30: Accounts Payable, Current $2.99M.
- 2024-03-31: Accounts Payable, Current $2.70M.
- 2023-12-31: Accounts Payable, Current $3.27M.
| Period end | Accounts Payable, Current |
|---|---|
| 2024-09-30 | $5.20M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.99M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $2.70M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.27M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $2.54M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.10M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $3.20M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.23M 10-K · filed 2024-03-07 |
| 2022-09-30 | $3.43M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.66M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.59M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $8.96M 10-K · filed 2023-03-09 |
| 2021-09-30 | $3.64M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.51M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.49M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $763.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.26M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.56M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $4.93M 10-K · filed 2021-03-11 |